Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

337
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
337

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAU Guidelines on Nonmuscle-invasive Bladder Cancer (TaT1 and CIS) - A Summary of the 2026 Guidelines Update.

European urology·2026
Same authorSame journal

Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making.

European urology oncology·2026
Same author

Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBC.

The French journal of urology·2026
Same author

Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.

European urology oncology·2026
Same author

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

CDO1 is a new biomarker to discriminate aggressive forms of prostate cancer.

Oncogene·2026

Related Experiment Video

Updated: Jun 7, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.6K

Anatomic Factors Associated with Complications After Radical Prostatectomy: A Systematic Review and Meta-analysis.

Arthur Peyrottes1, Charles Dariane2, Michael Baboudjian3

  • 1Comité de Cancérologie de l'Association Française d'Urologie, Paris, France; Department of Urology, Saint-Louis Hospital, Paris-Cité University, Paris, France.

European Urology Oncology
|November 19, 2024
PubMed
Summary

Anatomical factors like prostate volume significantly impact radical prostatectomy outcomes. Larger prostates increase operative time and complications but reduce positive surgical margins, aiding surgical planning.

Keywords:
Adverse eventsMedian lobeMeta-analysisOperative timeProstate cancerProstate volumeRadical prostatectomySurgical complicationsSurgical marginsSystematic review

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

7.7K

Related Experiment Videos

Last Updated: Jun 7, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

7.7K

Area of Science:

  • Urology
  • Surgical Oncology
  • Medical Anatomy

Background:

  • The influence of anatomical variations on radical prostatectomy (RP) outcomes is not well-defined.
  • Understanding these factors is crucial for predicting perioperative results in localized prostate cancer (PCa).

Purpose of the Study:

  • To systematically review and meta-analyze the impact of anatomical factors on perioperative outcomes following RP for PCa.
  • To identify specific anatomical predictors influencing surgical success and complications.

Main Methods:

  • A comprehensive literature search was performed across major databases (PubMed/Medline, Embase, Web of Science) up to January 2024.
  • Eligible studies were identified following PRISMA guidelines, with data pooled for meta-analysis.
  • Outcomes included operative time, blood loss, transfusion rates, complications, and positive surgical margins (PSMs).

Main Results:

  • Ninety-one studies were included. Larger prostate volume (PV) and weight correlated with increased operative time, blood loss, and complications (p < 0.05).
  • Increased PV and weight were also associated with a lower rate of positive surgical margins (PSMs) (p < 0.05).
  • Subgroup analysis indicated open surgery for large prostates had longer operative times and lower PSM rates compared to robotic approaches.

Conclusions:

  • Anatomical factors, especially prostate volume, are significant predictors of RP outcomes.
  • Larger prostates present a trade-off: higher complication risk but reduced likelihood of positive surgical margins.
  • Standardized outcome measures are needed for future research to refine clinical decision-making in RP.